Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Gross Profit (2022 - 2025)

HCW Biologics (HCWB) has disclosed Gross Profit for 4 consecutive years, with $3122.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Profit fell 96.34% year-over-year to $3122.0, compared with a TTM value of $84406.0 through Sep 2025, down 92.55%, and an annual FY2024 reading of $959403.0, up 71.21% over the prior year.
  • Gross Profit was $3122.0 for Q3 2025 at HCW Biologics, up from $1310.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $1.8 million in Q1 2022 and bottomed at $1013.0 in Q1 2025.
  • Average Gross Profit over 4 years is $274105.7, with a median of $166800.0 recorded in 2022.
  • The sharpest move saw Gross Profit surged 4805.03% in 2024, then crashed 99.84% in 2025.
  • Year by year, Gross Profit stood at $268304.0 in 2022, then decreased by 5.84% to $252645.0 in 2023, then crashed by 68.75% to $78961.0 in 2024, then plummeted by 96.05% to $3122.0 in 2025.
  • Business Quant data shows Gross Profit for HCWB at $3122.0 in Q3 2025, $1310.0 in Q2 2025, and $1013.0 in Q1 2025.